Abiopharma

🔍 Weil B. Luke (Director)

Company: Willow Lane Acquisition Corp. (WLAC)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 4,628,674 shares of Class A Ordinary Shares (Direct)
  Date: 2026-05-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,628,674.00 | transaction_form_type: 4 | Footnotes: F2, F1, F1
• Sold 4,628,674 shares of Class A Ordinary Shares (Direct)
  Date: 2026-05-08 | Code: U | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F1, F1
• Sold 4,628,674 shares of Class B Ordinary Shares (Derivative)
  Date: 2026-05-08 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2, F2, F2, F1, F1
• Acquired 4,007,222 shares of Warrants (Derivative)
  Date: 2024-11-07 | Code: J | equity_swap_involved: 0 | shares_owned_after: 4,007,222.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2, F2, F1, F1
• Sold 4,007,222 shares of Warrants (Derivative)
  Date: 2026-05-08 | Code: U | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2, F2, F2, F2, F1, F1

Footnotes:

• F1: Willow Lane Sponsor, LLC (the "Sponsor") is the record holder of the securities reported herein. B. Luke Weil is the sole managing member of the Sponsor and holds voting and investment discretion with respect to the securities held of record by the Sponsor. As such, B. Luke Weil may be deemed to have beneficial ownership of the securities held of record by the Sponsor. B. Luke Weil disclaims any beneficial ownership except to the extent of his pecuniary interest therein.
• F2: In connection with the closing of the business combination (the "Business Combination") on May 8, 2026 among Willow Lane Acquisition Corp. (the "Issuer"), Boost Run Holdings, LLC ("Boost Run"), Boost Run Inc. ("Pubco") and other parties named therein under that certain Business Combination Agreement, dated September 15, 2025 and amended on January 13, 2026, these Class A Ordinary Shares of the Issuer were cancelled in exchange for an equal number of shares of Class A common stock, par value $0.0001 per share, of Pubco. Following the Business Combination, the Sponsor and Mr. Weil own zero Class A Ordinary Shares of the Issuer.
• F3: As described in the registration statement on Form S-1, as amended (File No. 333-282495), of the Issuer under the heading "Description of Securities--Founder Shares," the Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior to the Issuer's initial business combination, at the option of the holder, on a one-for-one basis, subject to certain adjustments. On May 8, 2026, in connection with the consummation of the Business Combination, 4,628,674 Class B Ordinary Shares were converted into an aggregate of 4,628,674 Class A Ordinary Shares.
• F4: These warrants were purchased and issued on November 7, 2024, simultaneously with the closing of the Issuer's initial public offering and become exercisable 30 days after the completion of the Issuer's initial business combination. The warrants expire on a date that is five years after the completion of the Issuer's initial business combination.
• F5: In connection with the closing of the Business Combination, these warrants of the Issuer were cancelled in exchange for an equal number of warrants of Pubco. Following the Business Combination, the Sponsor and Mr. Weil own zero warrants of the Issuer.